On the eve of Bastille Day, Emmanuel Macron issued his warning in front of the French military instead of a health select committee, but the debate went farther than its context would have indicated. He informed his audience that nationalism in defence acquisition only results in future delays disguised as present-day conveniences. The occasion was the announcement that Ukraine, the UK, France, Germany and seven other nations would build a shared ballistic missile defence architecture, a project born from the collapse of a Franco-German fighter jet programme that had stalled for months under the weight of competing national interests. The lesson Macron drew was blunt. Fragmentation feels like sovereignty in the moment and reveals itself as vulnerability later.
Britain's health service has been relearning that same lesson for the better part of a decade, though rarely with anything like Macron's clarity of diagnosis.
The NHS Federated Data Platform was conceived as an answer to a problem strikingly similar to the one Macron described: a health system operating forty two integrated care boards' worth of local decision-making, incompatible electronic patient record systems, and data architecture that could not talk to itself even in a crisis. When the pandemic forced rapid data integration through what became the Covid Data Store, the value of a shared system was, briefly, undeniable. What has followed since is a slower and more familiar story. Trusts have resisted adoption. A parliamentary committee has called for Palantir's involvement to end altogether. Ministers are said to be weighing a break clause in a contract that runs, in its maximum form, to 2030. Meanwhile Palantir itself has publicly called for electronic patient record systems to become more interoperable with the platform, an unusual admission that the underlying fragmentation problem remains largely unsolved even by the system built to solve it.
This is where the Paris announcement becomes more than a foreign policy footnote. Macron's argument was not really about jets or missiles. It was about the political temptation, in any federated system under strain, to retreat into local control precisely when shared infrastructure would serve everyone better. Ten governments overcame that temptation for ballistic missile defence, judging the cost of duplicated national programmes higher than the discomfort of shared dependency. The NHS has not yet made an equivalent judgement about its data infrastructure, and the reasons are instructive rather than merely bureaucratic. Trust in a European coalition rests on the credibility of allied governments. Trust in a federated data platform rests on the credibility of a private contractor whose chief executive has spoken openly of running large segments of allied institutions on his company's software, and whose UK government contracts now extend across policing, defence and financial regulation as well as health. That difference in the nature of the counterparty is doing most of the political work here, and it explains why NHS trusts have been more ready to build their own local systems than European governments have been to build their own national missile shields.
There is a fiscal dimension too, though it deserves less weight than is often assumed. The Treasury now carries new commitments arising from Britain's contribution to the EU's Ukraine support loan, layered on top of NATO-driven defence spending pressure, at precisely the moment NHS capital budgets remain constrained by estate backlogs and unresolved electronic patient record procurement. The two budgets are not interchangeable in any given financial year, and it would be a mistake to present this as a straightforward contest between scanners and shields. What the two do share is a common political economy, in which the government must decide, repeatedly and under pressure, whether integration is worth the loss of local control it requires.
Macron's phrase was that patriotism, properly understood, chooses shared capability over solitary comfort. NHS leadership faces a quieter version of the same choice, absent the drama of a Paris summit, but the stakes for patients waiting on a system that still cannot fully see itself are no less real for that.
